Related Experiment Video
Updated: Jun 6, 2026

Prion Safety Laboratory Swipe Test
Published on: February 14, 2025
The risk of transmitting prion disease by blood or plasma products
1UK National CJD Surveillance Unit, University of Edinburgh, United Kingdom.
Abstract:
Various experimental studies have shown infectivity in blood in relation to bovine spongiform encephalitis (BSE) and variant Creutzfeldt-Jakob disease (vCJD). Human to human transmission vCJD infection has been reported via transfusion of non-leukocyte-reduced red cells and, probably, via factor VIII concentrates. A number of precautionary measures are in place but uncertainties remain, especially concerning the number of BSE-infected people in the population. Additional measures such as prion filtration need consideration.
Insights
Bovine spongiform encephalitis (BSE) and variant Creutzfeldt-Jakob disease (vCJD) can be transmitted through blood transfusions. Further research and prion filtration are needed to address remaining uncertainties in preventing transmission.
Area of Science:
- Neuroscience
- Infectious Diseases
- Public Health
Background:
- Experimental studies confirm blood infectivity for bovine spongiform encephalitis (BSE) and variant Creutzfeldt-Jakob disease (vCJD).
- Human transmission of vCJD has occurred through blood transfusions (non-leukocyte-reduced red cells) and potentially factor VIII concentrates.
Purpose of the Study:
- To review the evidence for bloodborne transmission of BSE and vCJD.
- To discuss current precautionary measures and identify areas of uncertainty.
- To recommend further strategies for preventing prion disease transmission.
Main Methods:
- Literature review of experimental studies and reported transmission cases.
- Analysis of existing safety measures in blood product handling.
- Discussion of potential risks and future mitigation strategies.
Main Results:
- Blood infectivity is established for BSE and vCJD.
- Documented human-to-human transmission via blood products highlights transfusion risks.
- Uncertainties persist regarding the prevalence of BSE infection in the human population.
Conclusions:
- Bloodborne transmission of vCJD is a proven risk.
- Current measures may not fully eliminate transmission risk.
- Prion filtration and further surveillance are crucial for enhanced safety.
More Related Videos
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Rh Blood Group
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Transmission of Pathogens
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Subviral Agents

